Financials data is unavailable for this security.
View more
Year on year NexgenRx Inc had net income fall 1,382.01% from a loss of 22.40k to a larger loss of 331.97k despite a 8.33% increase in revenues from 12.78m to 13.85m. An increase in the selling, general and administrative costs as a percentage of sales from 66.42% to 69.74% was a component in the falling net income despite rising revenues.
Gross margin | 78.14% |
---|---|
Net profit margin | -0.17% |
Operating margin | 0.01% |
Return on assets | -0.09% |
---|---|
Return on equity | -0.38% |
Return on investment | -0.29% |
More ▼
Cash flow in CADView more
In 2023, NexgenRx Inc increased its cash reserves by 6.22%, or 109.88k. The company earned 1.28m from its operations for a Cash Flow Margin of 9.23%. In addition the company used 248.41k on investing activities and also paid 919.06k in financing cash flows.
Cash flow per share | 0.0173 |
---|---|
Price/Cash flow per share | 14.44 |
Book value per share | 0.1117 |
---|---|
Tangible book value per share | 0.056 |
More ▼
Balance sheet in CADView more
Current ratio | 1.08 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0616 |
---|---|
Total debt/total capital | 0.058 |
More ▼